All In MedTech

FDA Clearance Tracker · P240012-S001

AeroPace® System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 30, 2025 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P240012-S001
Device name
AeroPace® System
Applicant location
Exton, PA
Received
Dec 31, 2024
Decided
Jan 30, 2025
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol
Original approval
P240012

Device type

Device class
Class III

Every decision under product code SDL

FDA's approval statement

As written in FDA's record.

Approval of the protocol for the post-approval study AERO-PAS.

Source documents

Other decisions for Lungpacer Medical USA, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.